User menu

Chemical analysis of solid-state irradiated human insulin.

Bibliographic reference Terryn, Hélène ; Vanhelleputte, Jean-Paul ; Maquille, Aubert ; Tilquin, Bernard. Chemical analysis of solid-state irradiated human insulin.. In: Pharmaceutical research, Vol. 23, no. 9, p. 2141-8 (2006)
Permanent URL http://hdl.handle.net/2078.1/10698
  1. E. S. Kempner. Effects of high-energy electrons and gamma rays directly on protein molecules. J. Pharm. Sci. 90:1637–1646 (2001).
  2. B. D. Reid, and B. P. Fairand. Sterilization of drugs and devices technologies for the 21st century. In F. M. Nordhauser, and W. P. Olson (eds.), Sterilization of Drugs and Devices Technologies for the 21st Century, Interpharm, Buffalo Grove, 1998, pp 311–392.
  3. The United States Pharmacopoeia USP. Sterilization and sterility assurance of compendial articles. 24th ed., Rockville, 2000, pp. 2143–2147.
  4. European Pharmacopoeia. Textes généraux sur la stérilité. 4th ed., Council of Europe, Strasbourg, 2000, pp. 439–444.
  5. ISO 11137. Sterilization of health care products—requirements for validation and routine control–radiation sterilization. International Standard for Organization, Switzerland, 1995.
  6. EN552. Sterilization of medical devices: validation and routine control of sterilization by irradiation. European Standardisation Organization, Brussels, 1994.
  7. The European Agency for the Evaluation of Medicinal Products (EMEA). Decision trees for the selection of sterilization methods (CPMP/QWP/054/98 corr), EMEA, London, 2000.
  8. N. Barbarin and B. Tilquin. Study of nonvolatile degradation compounds produced by radiosterilization of cefotaxime. Radiat. Phys. Chem. 60:359–367 (2001).
  9. The European Agency for the Evaluation of Medicinal Products (EMEA). ICH Topic Q3A Note for Guidance on Impurities testing: impurities in new drug substances. (CPMP/ICH/2737/99), EMEA, London, 2002.
  10. H. Terryn, V. Deridder, C. Sicard-Roselli, B. Tilquin, and C. Houée-Levin. Radiolysis of proteins in the solid state. An approach by EPR and product analysis. J. Synchrotron Radiat. 12:292–298 (2005).
  11. European Pharmacopoeia. Techniques de séparation chromatographique. 5th ed., Council of Europe, Strasbourg, 2005, pp. 72–77.
  12. D. A. Malencik, J. F. Sprouse, C. A. Swanson, and S. R. Anderson. Dityrosine: preparation, isolation, and analysis. Anal. Biochem. 242:202–213 (1996).
  13. S. Linde and B. S. Welinder. Non-ideal behaviour of silica-based stationary phases in trifluoroacetic acid-acetonitrile-based reversed-phase high-performance liquid chromatographic separations of insulins and proinsulins. J. Chromatogr. A. 536:43–55 (1991).
  14. A. W. Purcell, M. I. Aguilar, and M. T. W. Hearn. Conformational effects in reversed-phase high-performance liquid chromatography of polypeptides. I. Resolution of insulin variants. J. Chromatogr. A. 711:61–70 (1995).
  15. B. S. Welinder and H. S. Sørensen. Alternative mobile phases for the reversed-phase-high-performance liquid chromatography of peptides and proteins. J. Chromatogr. A. 537:181–199 (1991).
  16. J. Brange, S. Havelund, and P. Hougaard. Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. Pharm. Res. 9:727–734 (1992).
  17. N. Barbarin, B. Rollmann, and B. Tilquin. Role of residual solvents in the formation of volatile compounds after radiosterilisation of cefotaxime. Int. J. Pharm. 178:203–212 (1999).
  18. Darby S. M., Miller M. L., Allen R. O., LeBeau M., A Mass Spectrometric Method for Quantitation of Intact Insulin in Blood Samples, 10.1093/jat/25.1.8
  19. European Pharmacopoeia. Insuline humaine. 5th ed., Council of Europe, Strasbourg, 2005, pp. 1941–1943.
  20. M. Falconi, M. Bozzi, M. Paci, A. Raudino, R. Purrello, A. Cambria, M. Sette, and M. T. Cambria. Spectroscopic and molecular dynamics simulation studies of the interactions of insulin with glucose. Int. J. Biol. Macromol. 29:161–168 (2001).
  21. Y. Pocker and S. B. Biswas. Conformational dynamics of insulin in solution. Circular dichroic studies. Biochemistry. 19:5043–5049 (1980).
  22. L. Zixian. Ultraviolet circular dichroism of insulin and its analogs. Scientia Sinica 24:1566–1574 (1980).
  23. N. Barbarin, A. S. Crucq, and B. Tilquin. Study of volatile compounds from the radiosterilization of solid cephalosporine. Radiat. Phys. Chem. 48:787–794 (1996).
  24. J. Brange, O. Hallund, and E. Sørensen. Chemical stability of insulin. 5. Isolation, characterization and identification of insulin transformation products. Acta Pharmaceutica Nordica 4:223–232 (1992).
  25. S. Terabe, R. Konaka, and K. Inouye. Separation of some polypeptide hormones by high-performance liquid chromatography. J. Chromatogr. A. 172:163–177 (1979).
  26. A. Hvass, M. Hach, and M. U. Jars. Complementary analytical HPLC methods for insulin-related degradation products. Am. Biotechnol. Lab. 21:8–12 (2003).
  27. P. Moslemi, A. R. Najafabadi, and H. Tajerzadeh. A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 33:45–51 (2003).
  28. FISHER BARRY V., PORTER PATRICIA B., Stability of bovine insulin, 10.1111/j.2042-7158.1981.tb13758.x
  29. M. J. Pikal, and D. R. Rigsbee. The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form. Pharm. Res. 14:1379–1387 (1997).
  30. J. D. Hirst, S. Bhattacharjee, and A. V. Onufriev. Theoretical studies of time-resolved spectroscopy of protein folding. Faraday Discuss. 122:253–267 (2002).
  31. N. Sreerama, C. M. Manning, M. E. Powers, J. Zhang, D. P. Goldenberg, and R. W. Woody. Tyrosine, phenylalanine and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. Biochemistry. 38:10814–10822 (1999).
  32. V. N. Uversky, L. N. Garriques, I. S. Millett, S. Frokjaer, J. Brange, S. Domiach, and A. L. Fink. Prediction of association state of insulin using spectral parameters. J. Pharm. Sci. 92:847–858 (2003).
  33. A. Wallmer, J. Fleishauer, W. Strassburger, and H. Thiele. Side-chain mobility of the calculation of tyrosyl circular dichroism of proteins. Implications of a test with insulin and des-B1-phenylalanine insulin. Biophys. J. 20:233–243 (1977).
  34. Morris J.W.S., Mercola Daniel A., Arquilla Edward R., An analysis of the near ultraviolet circular dichroism of insulin, 10.1016/0005-2795(68)90080-9
  35. Mercola Daniel A., Morris J.W.S., Arquilla Edward R., Bromer William W., The ultraviolet circular dichroism of bovine insulin and desoctapeptide insulin, 10.1016/0005-2795(67)90062-1
  36. A. Chapelier, M. Desmadril, and C. Houée-Levin. Gamma radiation effects on α-lactalbumin: structural modifications. Can. J. Physiol. Pharm. 79:154–157 (2001).
  37. J. W. T. Spinks, and R. J. Woods. An Introduction to Radiation Chemistry, 3rd ed., Wiley, New-York, 1990.